Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
4,464
NCT02302170
A Phase Ⅲ Clinical Trial With Oral Recombinant Helicobacter Pylori Vaccine in Chinese Children
Phase: Phase 3
Role: Collaborator
Start: Dec 31, 2004
Completion: Sep 30, 2008